Biogen Pharmachem Industries Ltd — Insider Trading, 17-03-2026: Insider Trading / SAST

BIOGEN PHARMACHEM INDUSTRIES has initiated a trading window closure for company insiders. This is ahead of the upcoming announcement of its audited financial results for the recent quarter and full year. The window will reopen 48 hours post-declaration of these results. The company will inform stakeholders about the board meeting date where these results will be considered. This measure supports market integrity by ensuring no insider trading occurs before financial disclosures are public, benefiting all investors.